{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:05:46Z","timestamp":1771369546716,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1-2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.lfs.2013.10.003","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T23:16:16Z","timestamp":1382051776000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome"],"prefix":"10.1016","volume":"99","author":[{"given":"Yujun","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.lfs.2013.10.003_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00470-9","article-title":"How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH","volume":"86","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"issue":"25","key":"10.1016\/j.lfs.2013.10.003_bb0010","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lfs.2013.10.003_bb0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.lfs.2013.10.003_bb0020","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2005.05.098","article-title":"Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients with Decompensated Congestive Heart Failure (RAPID-CHF) trial","volume":"46","author":"Bart","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.lfs.2013.10.003_bb0025","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lfs.2013.10.003_bb0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/17482940701606913","article-title":"Prognostic markers in heart failure\u2014congestion, neurohormones, and the cardiorenal syndrome","volume":"9","author":"Blair","year":"2007","journal-title":"Acute Card Care"},{"issue":"23","key":"10.1016\/j.lfs.2013.10.003_bb0035","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2013.10.003_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurheartj\/ehi020","article-title":"The severe cardiorenal syndrome: \u2018Guyton revisited\u2019","volume":"26","author":"Bongartz","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lfs.2013.10.003_bb0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/bmj.326.7387.489","article-title":"Bilateral renovascular disease causing cardiorenal failure","volume":"326","author":"Brammah","year":"2003","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.lfs.2013.10.003_bb0050","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.lfs.2013.10.003_bb0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ki.1988.189","article-title":"Regulation of glomerular filtration rate in chronic congestive heart failure patients","volume":"34","author":"Cody","year":"1988","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.lfs.2013.10.003_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10741-011-9261-3","article-title":"Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome","volume":"17","author":"Colombo","year":"2012","journal-title":"Heart Fail Rev"},{"issue":"6","key":"10.1016\/j.lfs.2013.10.003_bb0065","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.lfs.2013.10.003_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0162-0134(02)00461-0","article-title":"Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells","volume":"91","author":"Crichton","year":"2002","journal-title":"J Inorg Biochem"},{"issue":"9","key":"10.1016\/j.lfs.2013.10.003_bb0075","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.lfs.2013.10.003_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease","volume":"53","author":"Damman","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.lfs.2013.10.003_bb0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.lfs.2013.10.003_bb0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lfs.2013.10.003_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.lfs.2013.10.003_bb0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000248762","article-title":"Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats","volume":"30","author":"Gill","year":"2009","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.lfs.2013.10.003_bb0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(99)00532-X","article-title":"Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure","volume":"35","author":"Gottlieb","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.lfs.2013.10.003_bb0110","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lfs.2013.10.003_bb0115","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cardfail.2010.04.006","article-title":"The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study","volume":"16","author":"Gottlieb","year":"2010","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.lfs.2013.10.003_bb0125","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jacc.2007.03.059","article-title":"Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study","volume":"50","author":"Greenberg","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"11A","key":"10.1016\/j.lfs.2013.10.003_bb0130","doi-asserted-by":"crossref","first-page":"17C","DOI":"10.1016\/j.amjcard.2005.03.008","article-title":"Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches","volume":"95","author":"Gullestad","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lfs.2013.10.003_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nutr.21.1.1","article-title":"Perspectives on nutritional iron deficiency","volume":"21","author":"Hallberg","year":"2001","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"10.1016\/j.lfs.2013.10.003_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurjhf\/hfn043","article-title":"Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology","volume":"11","author":"Heymans","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"10.1016\/j.lfs.2013.10.003_bb0145","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.lfs.2013.10.003_bb0150","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2011.03.069","article-title":"Vitamin D, parathyroid hormone, and cardiovascular events among older adults","volume":"58","author":"Kestenbaum","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.lfs.2013.10.003_bb0155","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.amjcard.2008.06.067","article-title":"Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004)","volume":"102","author":"Kim","year":"2008","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.lfs.2013.10.003_bb0160","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00005373-199905000-00021","article-title":"Tumor necrosis factor depresses myocardial contractility in endotoxemic swine","volume":"46","author":"Kraut","year":"1999","journal-title":"J Trauma"},{"issue":"15","key":"10.1016\/j.lfs.2013.10.003_bb0165","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jacc.2011.07.008","article-title":"Vitamin D and cardiovascular disease will it live up to its hype?","volume":"58","author":"Lavie","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lfs.2013.10.003_bb0170","first-page":"149","article-title":"Cardiorenal syndrome (in French)","volume":"48","author":"Ledoux","year":"1951","journal-title":"L'Avenir M\u00e9d"},{"issue":"9","key":"10.1016\/j.lfs.2013.10.003_bb0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5414\/CP201518","article-title":"Pharmacokinetics and pharmacodynamics of tonapofylline in subjects with severe renal impairment and in elderly subjects","volume":"49","author":"Li","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.lfs.2013.10.003_bb0180","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2013.10.003_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4330\/wjc.v3.i1.1","article-title":"Cardiorenal syndromes","volume":"3","author":"McCullough","year":"2011","journal-title":"World J Cardiol"},{"issue":"14","key":"10.1016\/j.lfs.2013.10.003_bb0190","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.lfs.2013.10.003_bb0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.lfs.2013.10.003_bb0200","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","article-title":"Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?","volume":"51","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"9167","key":"10.1016\/j.lfs.2013.10.003_bb0205","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","article-title":"Endotoxin and immune activation in chronic heart failure: a prospective cohort study","volume":"353","author":"Niebauer","year":"1999","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.lfs.2013.10.003_bb0210","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","article-title":"Cardiorenal interactions: insights from the ESCAPE trial","volume":"51","author":"Nohria","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.lfs.2013.10.003_bb0215","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/labinvest.2012.136","article-title":"Impaired post-infarction cardiac remodeling in chronic kidney disease is due to excessive renin release","volume":"92","author":"Ogawa","year":"2012","journal-title":"Lab Investig"},{"issue":"12","key":"10.1016\/j.lfs.2013.10.003_bb0220","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.lfs.2013.10.003_bb0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCHEARTFAILURE.111.960906","article-title":"Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation","volume":"4","author":"Parikh","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.lfs.2013.10.003_bb0230","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.111.064097","article-title":"Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation","volume":"125","author":"Rafiq","year":"2012","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.lfs.2013.10.003_bb0235","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2013.10.003_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10741-011-9232-8","article-title":"Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes","volume":"17","author":"Ronco","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.lfs.2013.10.003_bb0250","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.lfs.2013.10.003_bb0255","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.lfs.2013.10.003_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semnephrol.2011.11.015","article-title":"Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome","volume":"32","author":"Ronco","year":"2012","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1016\/j.lfs.2013.10.003_bb0260","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ajh.2010.206","article-title":"Impact of nephron number dosing on cardiorenal damage and effects of ACE inhibition","volume":"24","author":"Rothermund","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.lfs.2013.10.003_bb0270","doi-asserted-by":"crossref","first-page":"293938","DOI":"10.4061\/2011\/293938","article-title":"Cardiorenal syndrome in acute heart failure syndromes","volume":"2011","author":"Sarraf","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.lfs.2013.10.003_bb0265","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2215\/CJN.03150509","article-title":"Cardiorenal syndrome in acute decompensated heart failure","volume":"4","author":"Sarraf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.lfs.2013.10.003_bb0275","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ki.2008.145","article-title":"Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice","volume":"74","author":"Schnermann","year":"2008","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.lfs.2013.10.003_bb0280","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lfs.2013.10.003_bb0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jtemb.2007.06.002","article-title":"On risks and benefits of iron supplementation recommendations for iron intake revisited","volume":"21","author":"Sch\u00fcmann","year":"2007","journal-title":"J Trace Elem Med Biol"},{"issue":"6","key":"10.1016\/j.lfs.2013.10.003_bb0295","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10741-010-9194-2","article-title":"The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome","volume":"16","author":"Silverberg","year":"2011","journal-title":"Heart Fail Rev"},{"issue":"19","key":"10.1016\/j.lfs.2013.10.003_bb0300","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/0002-9149(90)91166-4","article-title":"Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy","volume":"66","author":"Stevenson","year":"1990","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.lfs.2013.10.003_bb0305","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.ajkd.2008.04.031","article-title":"Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial","volume":"52","author":"Suzuki","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.lfs.2013.10.003_bb0310","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/ndt\/gfl293","article-title":"Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis\u2014a randomized study","volume":"21","author":"Takahashi","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.lfs.2013.10.003_bb0315","doi-asserted-by":"crossref","first-page":"902 9.e2","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.lfs.2013.10.003_bb0320","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2013.10.003_bb0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.nutr.24.012003.132212","article-title":"Iron, ferritin, and nutrition","volume":"24","author":"Theil","year":"2004","journal-title":"Annu Rev Nutr"},{"issue":"9","key":"10.1016\/j.lfs.2013.10.003_bb0330","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurjhf\/hfq099","article-title":"Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease\/chronic heart failure patients","volume":"12","author":"van der Putten","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.lfs.2013.10.003_bb0335","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2012.04.001","article-title":"Where is the vitamin D receptor?","volume":"523","author":"Wang","year":"2012","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.lfs.2013.10.003_bb0340","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbiomolbio.2006.02.004","article-title":"Who, what, where and when-influences on cutaneous vitamin D synthesis","volume":"92","author":"Webb","year":"2006","journal-title":"Prog Biophys Mol Biol"},{"issue":"3","key":"10.1016\/j.lfs.2013.10.003_bb0345","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11897-007-0031-4","article-title":"Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure","volume":"4","author":"Wencker","year":"2007","journal-title":"Curr Heart Fail Rep"},{"issue":"2","key":"10.1016\/j.lfs.2013.10.003_bb0350","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjcard.2006.01.081","article-title":"Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] Trial)","volume":"98","author":"Yancy","year":"2006","journal-title":"Am J Cardio"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513005961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513005961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T23:25:41Z","timestamp":1539300341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320513005961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":68,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0024320513005961"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2013.10.003","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2013.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}